NEWSROOM | Galderma

IMCAS 2023: Galderma to share latest data demonstrating high aesthetic improvement and patient satisfaction across its innovative portfolio

"The Full Spectrum of Dermatology: A Diverse And Inclusive Atlas" Launches New, Free Online Image Gallery

Galderma, the pure-play dermatology category leader and maker of Cetaphil, celebrates grand opening of U.S. headquarters in Dallas

Sales data confirm Galderma’s range of anti-acne products is the No.1 choice globally

Galderma launches novel formulation with Alastin Skincare® A-Luminate Brightening Serum® developed to diminish the appearance of hyperpigmentation

Galderma announces intention to expand manufacturing and innovation footprint in Asia-Pacific

Galderma study paves the way for an effective, new acne treatment combination

New data from Galderma's aesthetics portfolio to be presented at 2022 ASDS Annual Meeting

Galderma and National Breast Cancer Foundation Announce Continued Partnership to Launch Campaign Elevating Skin Stories of Breast Cancer Survivors

Galderma expands with new production site in Uppsala, Sweden

Cetaphil® Celebrates 75 Years of Sensitive Skincare Leadership

Galderma debuts the Sensitive Skincare Faculty, a global expert group to improve understanding and management of sensitive skin